deadliest breast cancer

Release time ：Nov-11,2024

Breast cancer is one of the most prevalent malignancies among women, with triple-negative breast cancer potentially being the most deadly form. This subtype is challenging to treat and tends to have a poorer prognosis due to the absence of three common hormone receptors and the HER2 protein. Triple-negative breast cancer is considered one of the most lethal types because its biological properties render it less responsive to conventional endocrine and targeted therapies. These cancer cells proliferate quickly, are prone to metastasis, and carry a higher risk of recurrence. Moreover, the lack of specific therapeutic targets means that treatment for triple-negative breast cancer primarily depends on chemotherapy, which can have significant side effects and negatively impact patients' quality of life. Early diagnosis and a comprehensive treatment approach are vital for patients with triple-negative breast cancer. They should be vigilant about any changes in their bodies and seek medical attention promptly if abnormalities arise. Throughout treatment, patients should adhere to standardized protocols under a physician's guidance and avoid self-medicating without proper oversight. Maintaining a positive attitude and actively engaging in the treatment process are also crucial for improving survival rates.